DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients

NCT06388122 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer
Hormone-receptor-positive Breast Cancer
Metastatic Breast Cancer

Interventions

PROCEDURE: Biospecimen Collection

Sponsor

Mayo Clinic